Antonia A. Nikitenko

430 total citations
18 papers, 271 citations indexed

About

Antonia A. Nikitenko is a scholar working on Organic Chemistry, Molecular Biology and Pharmaceutical Science. According to data from OpenAlex, Antonia A. Nikitenko has authored 18 papers receiving a total of 271 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 8 papers in Molecular Biology and 4 papers in Pharmaceutical Science. Recurrent topics in Antonia A. Nikitenko's work include Respiratory viral infections research (4 papers), Fluorine in Organic Chemistry (4 papers) and Carbohydrate Chemistry and Synthesis (3 papers). Antonia A. Nikitenko is often cited by papers focused on Respiratory viral infections research (4 papers), Fluorine in Organic Chemistry (4 papers) and Carbohydrate Chemistry and Synthesis (3 papers). Antonia A. Nikitenko collaborates with scholars based in United States, Russia and Canada. Antonia A. Nikitenko's co-authors include Stanley A. Lang, Boris Feld, Boris Arshava, Bryan O’Hara, Anna Gazumyan, Juliette O’Connell, Ving J. Lee, Gregory A. Prince, Timothy D. Murphy and Philip R. Wyde and has published in prestigious journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and Tetrahedron.

In The Last Decade

Antonia A. Nikitenko

17 papers receiving 258 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antonia A. Nikitenko United States 10 123 102 75 56 32 18 271
Hongying Yun China 14 395 3.2× 157 1.5× 123 1.6× 73 1.3× 13 0.4× 20 642
Mohammad Shafiei Iran 12 140 1.1× 97 1.0× 79 1.1× 94 1.7× 19 0.6× 31 485
Takashi Nishigaki Japan 12 100 0.8× 43 0.4× 264 3.5× 94 1.7× 25 0.8× 23 411
Raj K. Sehgal United States 11 106 0.9× 67 0.7× 131 1.7× 57 1.0× 21 0.7× 35 335
Jeri S. Roth United States 11 111 0.9× 135 1.3× 249 3.3× 240 4.3× 65 2.0× 18 514
Xiufang Zheng China 9 151 1.2× 92 0.9× 67 0.9× 43 0.8× 5 0.2× 30 364
Dmitry V. Kravchenko Russia 11 225 1.8× 47 0.5× 112 1.5× 33 0.6× 5 0.2× 39 388
Lee T. Schaller United States 6 148 1.2× 58 0.6× 64 0.9× 136 2.4× 12 0.4× 7 313
Chia‐Liang Tai Taiwan 9 193 1.6× 51 0.5× 112 1.5× 83 1.5× 7 0.2× 11 387

Countries citing papers authored by Antonia A. Nikitenko

Since Specialization
Citations

This map shows the geographic impact of Antonia A. Nikitenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonia A. Nikitenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonia A. Nikitenko more than expected).

Fields of papers citing papers by Antonia A. Nikitenko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonia A. Nikitenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonia A. Nikitenko. The network helps show where Antonia A. Nikitenko may publish in the future.

Co-authorship network of co-authors of Antonia A. Nikitenko

This figure shows the co-authorship network connecting the top 25 collaborators of Antonia A. Nikitenko. A scholar is included among the top collaborators of Antonia A. Nikitenko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonia A. Nikitenko. Antonia A. Nikitenko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Zapf, Christoph W., Jonathan D. Bloom, Zhong Li, et al.. (2011). Discovery of a stable macrocyclic o-aminobenzamide Hsp90 inhibitor which significantly decreases tumor volume in a mouse xenograft model. Bioorganic & Medicinal Chemistry Letters. 21(15). 4602–4607. 24 indexed citations
2.
Alimardanov, Asaf, Antonia A. Nikitenko, Mousumi Ghosh, et al.. (2009). Large-Scale Synthesis of a Selective Inhibitor of the Norepinephrine Transporter: Mechanistic Aspects of Conversion of Indolinone Diol to Indolinone Aminoalcohol and Process Implications. Organic Process Research & Development. 13(5). 880–887. 4 indexed citations
3.
Alimardanov, Asaf, Antonia A. Nikitenko, Terrence J. Connolly, et al.. (2009). Practical Enantioselective Synthesis of a 3-Aryl-3-trifluoromethyl-2-aminopropanol Derivative. Organic Process Research & Development. 13(6). 1161–1168. 26 indexed citations
4.
Nikitenko, Antonia A., Asaf Alimardanov, J. Schmid, et al.. (2008). First Scale-Up Synthesis of WAY-262398, a Novel, Dual-Acting SSRI/5HT1a Antagonist. Organic Process Research & Development. 13(1). 91–97. 6 indexed citations
5.
Nikitenko, Antonia A.. (2007). Compound Scale‐Up at the Discovery—Development Interface. ChemInform. 38(24). 1 indexed citations
6.
Nikitenko, Antonia A., Deborah A. Evrard, Annmarie L. Sabb, et al.. (2007). First Scale-Up: Problems and Resolutions on the Synthesis of WAY-253752, a Novel, Dual-Acting SSRI/5HT1A Antagonist. Organic Process Research & Development. 12(1). 76–80. 22 indexed citations
7.
Nikitenko, Antonia A.. (2006). Compound scale-up at the discovery-development interface.. PubMed. 9(6). 729–40.
8.
Nikitenko, Antonia A., Michael W. Winkley, Kenneth A. M. Kremer, et al.. (2006). Selective Hydrolysis of Ethyl 5,6-Dihydro-4H-pyrrolo[1,2-b]pyrazole-2-carboxylate and Ethyl 5,6-Dihydro-4H-pyrrolo[1,2-b]pyrazole-3-carboxylate as a Key Step in the Large-Scale Synthesis of Bicyclic Heteroaryl Carboxyaldehydes. Organic Process Research & Development. 10(4). 712–716. 14 indexed citations
9.
Nikitenko, Antonia A., et al.. (2004). Pyrimidine containing RSV fusion inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(2). 427–430. 2 indexed citations
10.
Gopalsamy, Ariamala, John W. Ellingboe, Antonia A. Nikitenko, et al.. (2004). Design and Syntheses of 1,6-Naphthalene Derivatives as Selective HCMV Protease Inhibitors. Journal of Medicinal Chemistry. 47(8). 1893–1899. 13 indexed citations
11.
Huntley, Clayton C., Jason Weiss, Anna Gazumyan, et al.. (2002). RFI-641, a Potent Respiratory Syncytial Virus Inhibitor. Antimicrobial Agents and Chemotherapy. 46(3). 841–847. 54 indexed citations
12.
Nikitenko, Antonia A., et al.. (2001). The discovery of RFI-641 as a potent and selective inhibitor of the respiratory syncytial virus. Bioorganic & Medicinal Chemistry Letters. 11(8). 1041–1044. 27 indexed citations
13.
Ding, Weidong, Girija Krishnamurthy, Ann Aulabaugh, et al.. (1998). Novel and Specific Respiratory Syncytial Virus Inhibitors That Target Virus Fusion. Journal of Medicinal Chemistry. 41(15). 2671–2675. 36 indexed citations
14.
Nikitenko, Antonia A., et al.. (1998). Effect of A(1,3)-cis strain on the asymmetric epoxidation of (E)- and (Z)-6,6-diethoxy-3-hexen-2-ols and 4-methyl-6,6-diethoxy-3-hexen-2-ols. Tetrahedron. 54(39). 11731–11740. 3 indexed citations
16.
Shutalev, Anatoly D., Boris Arshava, Antonia A. Nikitenko, et al.. (1994). Synthesis and crystal structure of 3′-fluoro-3′-methyl-2′,3′-dideoxythymidine. inhibitory properties of 3′-fluoro-3′-methyl-2′,3′-dideoxythymidine-5′-triphosphate in the synthesis of DNA in cell-free media. Bioorganic & Medicinal Chemistry Letters. 4(5). 761–768. 1 indexed citations
17.
Nikitenko, Antonia A., et al.. (1992). A novel reagent for regioselective cleavage of 2,3-epoxyalcohols by fluoride - a synthesis of 3-fluoro-293-dideoxy-d-erythro-pentose.. Tetrahedron Letters. 33(47). 7087–7088. 16 indexed citations
18.
Arshava, Boris, et al.. (1992). Total stereo- and enantio-selective synthesis of 2,3-dideoxy-3-C-methylene-d-glycero-pentose and its ethyl furanosides. Carbohydrate Research. 224. 103–109. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026